← Eichor
Study identifier: NCT04802135 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy

Condition: Epileptic Encephalopathy  ·  Sponsor: Assistance Publique Hopitaux De Marseille

PhaseN/A
Planned participants200
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Electrical activity emerges in the third trimester of pregnancy, plays an important role in the construction of cortical maps, and is impaired in patients with severe early epileptic encephalopathies (EOEE). EOEE are rare and severe epileptic syndromes characterized by epilepsy that begins within the first three months of life and is associated with rapid deterioration of motor, cognitive and behavioral skills. There is a genetic basis for the EOEE. Together with other laboratories, the investigators have identified de novo pathogenic variants in the KCNQ2 gene encoding the Kv7.2 subunit of the Kv7 / M potassium channel, a channel known to control neuronal excitability in the brain and spinal cord. via the current M (IM). Pathogenic variants of the KCNQ2 gene represent the main cause of EOEE and the term KCNQ2-related epileptic encephalopathy (KCNQ2-REE) is now used to define this condition. KCNQ2-REE patients have a remarkably homogeneous phenotype at the start, with epilepsy that begins in the first days after birth, seizures that result in tonic muscle spasms that last from 1 to 10 seconds, and an interictal EEG called "suppression-burst". "That is, paroxysmal bursts of activity interspersed with periods of electrical silence. In this group, more than 50% of the patients present a remission of the epilepsy and a quasi-normalization of the EEG which can occur a few weeks to several months after the onset of the seizures. Despite this positive evolution in terms of seizure…

This description comes directly from the study's public registry record.

Talk to the study team

Mathieu Milh  ·  0491322903  ·  mathieu.milh@ap-hm.fr

Always discuss trial participation with your own doctor first.

Locations (15)

CHU AngersAngers, FranceNot Yet Recruiting
CHU BordeauxBordeaux, FranceNot Yet Recruiting
CHU BrestBrest, FranceNot Yet Recruiting
CHRU LilleLille, FranceNot Yet Recruiting
CHU LimogesLimoges, FranceNot Yet Recruiting
Hospices Civils LyonLyon, FranceNot Yet Recruiting
Hôpital La TimoneMarseille, FranceRecruiting
CHU MontpellierMontpellier, FranceNot Yet Recruiting
APHP Pitié SalpêtrièreParis, FranceRecruiting
APHP Robert DebréParis, FranceNot Yet Recruiting
Hôpital NeckerParis, FranceNot Yet Recruiting
CHU RennesRennes, FranceNot Yet Recruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04802135